Lixte Biotechnology Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIXT research report →
About the company
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to act upon these targets.
- CEO
- Geordan G. Pursglove
- IPO
- 2007
- Employees
- 2
- HQ
- Pasadena, CA, US
Price Chart
- Market Cap
- $89.11M
- P/E
- -6.38
- P/S
- 0.00
- P/B
- 9.88
- EV/EBITDA
- -11.86
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -125.56%
- ROIC
- -62.41%
- Revenue
- $0 · 0.00%
- Net Income
- $-6,009,520 · -67.58%
- EPS
- $-1.26 · 20.75%
- Op Income
- $-5,107,621
- FCF YoY
- 2.97%
- 52W High
- $8.38
- 52W Low
- $2.02
- 50D MA
- $5.83
- 200D MA
- $4.31
- Beta
- 1.25
- Avg Volume
- 235.47K
Get TickerSpark's AI analysis on LIXT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Stazzone Peter | other | 50,000 |
| Jul 1, 26 | Sawyer Jason David | other | 40,000 |
| Jul 1, 26 | Pursglove Geordan Garrett | other | 350,000 |
| Jul 1, 26 | Primus Guy Warren | other | 15,000 |
| Jul 1, 26 | Holloway Michael Andrew | other | 15,000 |
| Jul 1, 26 | Felix Lourdes | other | 30,000 |
| Jul 1, 26 | Travaglini John Francis | other | 0 |
| May 29, 26 | Porter Stuart D | other | 25,000 |
| May 29, 26 | Porter Stuart D | other | 0 |
| Apr 15, 26 | Pursglove Geordan Garrett | other | 350,000 |
Our LIXT coverage
Recent articles, reports, and earnings notes.
No research on LIXT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LIXT report →Similar companies
Peers in the same neighborhood.